Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Ghimire, Prakash ^a   Singh, Nihal ^a   Ortega, Leonard ^a   Rijal, Komal Raj ^b   Adhikari, Bipin ^c   Thakur, Garib Das ^d   Marasini, Baburam ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b TRIBHUVAN UNIVERSITY   (Nepal)

^c MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^d Minister for Health and Population Nepal   (Nepal)

Author keywords

Antimalarial drugs; Ethnic group; G6PDd; Malaria; Nepal; Risk

Indexed keywords

PRIMAQUINE;

ADULT; ARTICLE; BLOOD SAMPLING; BRAHMIN (PEOPLE); CHHETRI (PEOPLE); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; NEPAL; POPULATION RESEARCH; PREVALENCE; RAJBANSHI (PEOPLE); RAPID TEST; RISK ASSESSMENT; SEX DIFFERENCE; THARU (PEOPLE); VULNERABLE POPULATION; ADOLESCENT; CHILD; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA; MALE; MIDDLE AGED; NEPAL; PREVALENCE; YOUNG ADULT;

EID: 85019885947     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1864-2     Document Type: Article

References (41)

1. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, et al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012;6:e1814.
2. Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26:36-57.
3. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151-201.
4. Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and treatment of Plasmodium vivax malaria. Am J Trop Med Hyg. 2016;95(Suppl 6):35-51.
5. Beutler E, Dern RJ, Alving AS. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med. 1954;44:177-84.
6. Beutler E, Duparc S, G6PD Deficiency Working Group. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77:779-89.
7. Howes R, Piel F, Patil A, Nyangiri O, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries, a geostatistical model based map. PLoS Med. 2012;9:e1001339.
8. Alving A, Carson P, Flanagan C, Ickes C. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science. 1956;124:484-5.
9. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ. 1981;59:391-5.
10. WHO. Guidelines for the treatment of malaria. 3rd ed. 2015. http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf. Accessed 30 Oct 2016.
11. Frank J. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277-82.
12. Ganczakowski M, Town M, Bowden D, Vulliamy T, Kaneko A, Clegg J, et al. Multiple glucose 6-phosphate dehydrogenase deficient variants correlate with malaria endemicity in the Vanuatu archipelago (Southwestern Pacific). Am J Hum Genet. 1995;56:294-301.
13. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science. 2009;326:1546-9.
14. WHO. Malaria elimination. A field manual for low and moderate endemic countries. 2007. http://apps.who.int/iris/bitstream/10665/43796/1/9789241596084_eng.pdf. Accessed 30 Oct 2016.
15. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar J. 2008;7(Suppl 1):S8.
16. Epidemiology & Disease Control Division Department of Health Services, Ministry of Health & Population: draft internal assessment of the National Malaria Control Programme-Nepal 2009. http://www.dohs.gov.np/wp-content/uploads/2014/04/Internal_assessment_5.doc. Accessed 30 Oct 2016.
17. Epidemiology & Disease Control Division, DoHS, Ministry of Health, Nepal. National malaria treatment protocol-2015. https://drive.google.com/file/d/0B9_ePLqoRRtqUG1mLXl4QXpwME0/view. Accessed 30 Oct 2016.
18. Epidemiology & Disease Control Division Department of Health Services, Ministry of Health & Population. Annual report 2012/13. http://dohs.gov.np/wp-content/uploads/2014/04/Annual_Report_2069_70.pdf. Accessed 30 Oct 2016.
19. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE. 2011;6:e28357.
20. Tinley K, Loughlin A, Jepson A, Barnett E. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2010;82:210-4.
21. White N, Qiao L, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012;11:418.
22. Hay S, Guerra C, Tatem AJ, Noor A, Snow R. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4:327-36.
23. Mahgoub H, Gasim G, Musa IR, Adam I. Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan. Parasites Vectors. 2012;5:154.
24. Harris I, Sharrock WW, Bain L, Gray K, Bobogare A, Boaz L, et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J. 2010;9:254.
25. Baird J, Surjadjaja C. Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2011;27:11-6.
26. Arain YH, Bhutani VK. Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification. Indian J Pediatr. 2014;81:599-607.
27. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa. PLoS One. 2015;10:e0125796.
28. Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg. 2015;92:22-7.
29. Cappellini M, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet Infect Dis. 2008;371:64-74.
30. Leslie T, Moiz B, Mohammad N, Amanzai O, Ur Rasheed H, Jan S, et al. Prevalence and molecular basis of G6PD deficiency in Afghan populations: implications for treatment policy in the region. Malar J. 2013;12:230.
31. Kuwahata M, Wijesinghe R, Ho M, Pelecanos A, Bobogare A, Landry L, et al. Population screening for G6PD deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J. 2010;9:223.
32. Baxi A, Balakrishanan V, Undevi J, Sanghvi L. Glucose-6-phosphate dehydrogenase deficiency in the Parsee community, Bombay. Indian J Med Sci. 1963;17:493-500.
33. Terrenato L, Shrestha S, Dixit K, Luzzatto L, Modiano G, Morpurgo G, et al. Decreased malaria morbidity in the Tharu people compared to sympatric populations in Nepal. Ann Trop Med Parasitol. 1988;82:1-11.
34. Sakai Y, Kobayashi S, Shibata H, Furuumi H, Endo T, Fucharoen S, et al. Molecular analysis of alpha-thalassemia in Nepal: correlation with malaria endemicity. J Human Genet. 2000;45:127-32.
35. Shigeru K. Cultural and biological adaptations to malaria in Nepal. Bull Grad Sch Soc Cult Stud Kyushu Univ. 1996;2:59-73.
36. Mukherjee MB, Colah RB, Martin S, Ghosh K. Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India-Country scenario. Indian J Med Res. 2015;141:516-20.
37. Rai V, Kumar P. Epidemiological study of glucose-6-phosphate dehydrogenase deficiency in scheduled caste population of India. J Anthropol. 2012;2012:984180.
38. Matsuoka H, Jichun W, Hirai M, Yoshida S, Arai M, Ishii A, et al. Two cases of glucose-6-phosphate dehydrogenase-deficient Nepalese belonging to the G6PD Mediterranean-type, not India-Pakistan subtype but Mediterranean-Middle East sub-type. J Hum Genet. 2003;48:275-7.
39. Beutler E. G6PD deficiency. Blood. 1994;84:3613-36.
40. Peters AL, Van Noorden CJ. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009;57:1003-11.
41. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.